Taxes
Latest in Taxes
US 100% Tariff on Branded Drugs: Implications and Carve-Outs
Starting October 1, 2025, the U.S. will levy a 100% tariff on imported branded/patented drugs, with an exemption for firms…
Funding EB-5 from India under RBI LRS: pooling, gifts, and steps
Families use RBI’s LRS (USD 250,000 per year) plus co-ownership, cross-year timing, or gifts to assemble EB-5 capital. AD Cat-I…
US Pushes Market Reforms on India and Brazil Amid Tariff Pressure
The U.S. imposed heavy 2025 tariffs—50% on many Indian and Brazilian exports—and tightened de minimis rules to pressure both countries…
India-U.S. Talks Face Section 232 Tariffs, Casting Doubt on a Deal
The U.S. widened Section 232 probes into key sectors, including a planned 100% pharma tariff from October 2025, undermining India-U.S.…
Finance Ministry: H-1B Fee Shock Real, Yet Manageable for India
India says the U.S. one-time USD 100,000 H-1B fee risks IT export earnings and jobs but can be managed through…
Why Make America Great Again Persists Despite U.S. Global Lead
The White House plan imposes a 10% baseline tariff, higher targeted duties including 100% on some Indian drugs, and a…
H-1B Fee Hike Spurs Remote Overseas Hiring by U.S. Firms
Effective September 21, 2025, a $100,000 surcharge applies to new H-1B petitions, with no payment process yet available. The fee…
India Could Benefit as U.S. H-1B Fee Pushes Talent Home
The U.S. will impose a $100,000 one-time fee on new H-1B petitions filed after September 21, 2025, exempting renewals. Experts…